Hyoscine butyl bromide
Hyoscine butyl bromide is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Trial for Peroperative Procedure and Postoperative Pain After Rectal Misoprostol or Rectal Hyoscine Administration
Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
Hyoscine Butyl Bromide for Management of Prolonged Labor
Hyoscine Butyl Bromide in Reducing Pain During HSG
Clinical Trials (7)
A Trial for Peroperative Procedure and Postoperative Pain After Rectal Misoprostol or Rectal Hyoscine Administration
Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
Hyoscine Butyl Bromide for Management of Prolonged Labor
Hyoscine Butyl Bromide in Reducing Pain During HSG
The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor
The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7